Experimental study of nitric oxide in decreasing intestinal mesenteric arterial hypocontractility in rats with hepatic cirrhosis and portal hypertension
Meng Luo,Wei Chen,Jun Qin,Dejun Liu,Jianxia Liu,Lei Qin,Haixin Qian
DOI: https://doi.org/10.3760/cma.j.issn.1673-9752.2013.03.015
2013-01-01
Abstract:Objective To investigate the mechanisms of nitric oxide (NO) in decreasing intestinal mesenteric arterial hypocontractility in rats with hepatic cirrhosis and portal hypertension, and to analyze the interaction of NO and RhoA/ROCK pathway. Methods The levels of NO in the peripheral blood and mesenteric artery of normal rats (normal control group, 5 rats), rats with portal hypertension (experimental control group, 6 rats) and rats with portal hypertension treated by L-NAME (L-NAME group, 6 rats) were detected. Mesenteric arteriole contractility to norepinephrine in the 3 groups was determined using a vessel perfusion system. The expressions of proteins of NO-cGMP-PKG pathway and RhoA/ROCK pathway in the 3 groups were detected by Western blot. All data were analyzed using the analysis of variance or LSD-t test. The changes of mesenteric arteriole contractility to norepinephrine was expressed in dose-response curve, and was analyzed using the nonlinear regression method, and the EC50 value was calculated. Results (1) The pressures of portal veins of the normal control group, experimental control group and L-NAME group were (6.2±0.9) mm Hg (1 mm Hg= 0.133 kPa),(13.9±1.7) mm Hg and (16.6±1.3) mm Hg, respectively, with a significant difference among the 3 groups (F= 94.4, P< 0.05).(2) The levels of NO in the normal control group, experimental control group and L-NAME group were (43±5) μmol/L,(82±16) μmol/L and (45±9) μmol/L, respectively, with a significant difference among the 3 groups (F= 24.77, P< 0.05). The level of NO of the L-NAME group was significantly lower than that of the experimental control group (P< 0.05).(3 …